ACTIVE

S.A. Laboratoires Pharmaceutiques Trenker

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result625,1 k €+158,8 %over 1 year

Revenue29 M €+1,7 %over 1 year

Equity6,4 M €+10,9 %over 1 year

Workforce88,2 ETP-0,8 %over 1 year

Identity

Source · BCE/KBO

S.A. Laboratoires Pharmaceutiques Trenker is a Public limited company incorporated in 1983. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Nivelles. It employs on average 88,2 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0423.960.076
Incorporation: 21/01/1983
Legal form: Public limited company
Registered office: Avenue Thomas Edison 32
1402 Nivelles · WallonieSee on map
Contributed capital: 3 676 432,00 €
Latest accounts: 31/12/2025
Average workforce: 88,2 ETP

Activities (NACE)

21100Manufacture of basic pharmaceutical products· main 21100Manufacture of basic pharmaceutical products 21201Manufacture of pharmaceutical preparations 21201Manufacture of pharmaceutical preparations 24410Precious metals production 24421Aluminium production

Joint committees (3)

Contacts

2 public details availableLog in to view

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 21 filings

Trend over 17 financial years

	2025		2024		2023		2022		2021
Income statement
Revenue	29 M €	+1.7%	28,5 M €	+2.0%	27,9 M €	+2.0%	27,3 M €	-3.2%	28,3 M €
EBITDA	1,3 M €	-12.8%	1,5 M €	-8.9%	1,7 M €	+257%	469,3 k €	-75.5%	1,9 M €
Operating result	912,2 k €	+18.8%	768,1 k €	-28.1%	1,1 M €	+524%	-251,9 k €	-119%	1,3 M €
Net result	625,1 k €	+159%	241,5 k €	-70.4%	816,6 k €	+299%	-410,3 k €	-141%	993,1 k €
Balance sheet
Equity	6,4 M €	+10.9%	5,7 M €	-3.1%	5,9 M €	+0.8%	5,9 M €	-6.5%	6,3 M €
Total assets	16,1 M €	-4.1%	16,8 M €	+8.5%	15,5 M €	-2.5%	15,9 M €	-3.2%	16,4 M €
Cash	423 k €	-82.0%	2,3 M €	+114%	1,1 M €	+100%	547,5 k €	-13.6%	633,5 k €
Debts	9,7 M €	-11.0%	10,9 M €	+13.8%	9,6 M €	-4.5%	10 M €	-1.0%	10,1 M €
Other
Workforce	88,2 ETP	-0.8%	88,9 ETP	-1.8%	90,5 ETP	-4.7%	95,0 ETP	-3.1%	98,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 5 M€ and 10 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 21 ended

Active mandates

ERUDITE

Director · since 27 juin 2024 · until 26 juin 2030 · 0731.714.550

Represented by Louis Declerck

Active

Foxfin

Director · since 27 juin 2024 · until 26 juin 2030 · 0889.988.460

Represented by Barbara De Saedeleer

Active

Medeca

Director · since 27 juin 2024 · until 26 juin 2030 · 0799.616.134

Represented by Charles Declerck

Active

Ended mandates

Daniel CATOUL

Director · since 16 novembre 2018 · until 27 juin 2024

Ended

Daniel CATOUL

Director · since 16 novembre 2018 · until 16 novembre 2024

Ended

Pascale Trenker

Director · since 16 novembre 2018 · until 16 novembre 2024

Ended

Pascle TRENKER

Director · since 16 novembre 2018 · until 27 juin 2024

Ended

Other companies at this address

Avenue Thomas Edison 32 1402 Nivelles

Company	CBE no.
T.DIFFUSION● Active	0418.157.102
TRENKER NUTRITION● Active	0688.640.216
Unité TRENKER● Active	0654.908.960

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	29/06/2026	29/07/2025	14/06/2024	20/06/2023	16/06/2022	09/06/2021
General meeting	05/06/2026	30/05/2025	31/05/2024	26/05/2023	27/05/2022	28/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 21 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	05/06/2026	29/06/2026	French	PDF
Full model	31/12/2024	30/05/2025	29/07/2025	French	PDF
Full model	31/12/2023	31/05/2024	14/06/2024	French	PDF
Full model	31/12/2022	26/05/2023	20/06/2023	French	PDF
Full model	31/12/2021	27/05/2022	16/06/2022	French	PDF
Full model	31/12/2020	28/05/2021	09/06/2021	French	PDF
Full model	31/12/2019	15/06/2020	03/08/2020	French	PDF
Full model	31/12/2018	31/05/2019	28/06/2019	French	PDF
Full model	31/12/2017	25/05/2018	22/06/2018	French	PDF
Full model	31/12/2016	26/05/2017	03/07/2017	French	PDF
Full model	30/06/2015	27/11/2015	18/12/2015	French	PDF
Full model	30/06/2014	28/11/2014	08/12/2014	French	PDF
Full model	30/06/2013	07/02/2014	17/02/2014	French	PDF
Full model	30/06/2012	30/11/2012	20/12/2012	French	PDF
Full model	30/06/2011	28/12/2011	25/01/2012	French	PDF
Full model	30/06/2010	15/01/2011	21/03/2011	French	PDF
Full model	30/06/2009	16/11/2009	25/11/2009	French	PDF
Full modelCorrection	30/06/2008	03/11/2008	21/04/2010	French	PDF
Full model	30/06/2008	03/11/2008	08/12/2008	French	PDF
Abridged model	30/06/2007	29/10/2007	10/07/2008	French	PDF
Abridged model	30/06/2006	30/10/2006	07/02/2007	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 5 M€ and 10 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 21 ended

Active mandates

ERUDITE

Director · since 27 juin 2024 · until 26 juin 2030 · 0731.714.550

Represented by Louis Declerck

Active

Foxfin

Director · since 27 juin 2024 · until 26 juin 2030 · 0889.988.460

Represented by Barbara De Saedeleer

Active

Medeca

Director · since 27 juin 2024 · until 26 juin 2030 · 0799.616.134

Represented by Charles Declerck

Active

Ended mandates

Daniel CATOUL

Director · since 16 novembre 2018 · until 27 juin 2024

Ended

Daniel CATOUL

Director · since 16 novembre 2018 · until 16 novembre 2024

Ended

Pascale Trenker

Director · since 16 novembre 2018 · until 16 novembre 2024

Ended

Pascle TRENKER

Director · since 16 novembre 2018 · until 27 juin 2024

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates17/09/2026
DEMISSIONS, NOMINATIONS
PDF
Other10/09/2025
ASSEMBLEE GENERALE - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates24/03/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates24/09/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates05/08/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates05/01/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates10/06/2021
DEMISSIONS, NOMINATIONS
PDF
Mandates31/12/2018
DEMISSIONS, NOMINATIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 2025625,1 k €↑
2024
Annual accounts 2024241,5 k €↓
2023
Annual accounts 2023816,6 k €↑
2022
Annual accounts 2022-410,3 k €↓
2021
Annual accounts 2021993,1 k €↓
2020
Annual accounts 20201,1 M €↑
2019
Annual accounts 2019-55,5 k €↑
2018
Annual accounts 2018-600,1 k €↓
2017
Annual accounts 2017469,2 k €↑
2016
Annual accounts 2016224,6 k €↓
2015
Annual accounts 2015749,6 k €↑
2014
Annual accounts 2014126,8 k €↑
2013
Annual accounts 201384,4 k €↓
2012
Annual accounts 2012386,2 k €↓
2010
Annual accounts 2010504,9 k €↓
2009
Annual accounts 2009610,4 k €↑
2007
Annual accounts 2007213,4 k €
21/01/1983
IncorporationPublic limited company

S.A. Laboratoires Pharmaceutiques Trenker

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline